REQUEST A DEMO
Total
USD $0.00
Search more companies

Sus Vacunas S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores | Ambulatory Health Care Services
Full name: Sus Vacunas S.A.S Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sus Vacunas S.A.S is based in Colombia. The head office is in Barranquilla. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on April 28, 2003. The company’s latest financial report indicates a net sales revenue increase of 5.02% in 2023. Its total assets grew by 10.88% over the same period. The net profit margin of Sus Vacunas S.A.S decreased by 2.91% in 2023.

Headquarters
Cr 49B No.79 - 01 Lc12 Cc Plaza Del Prado
Barranquilla; Atlantico;

Contact Details: Purchase the Sus Vacunas S.A.S report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sus Vacunas S.A.S report to view the information.
Incorporation Date:
April 28, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Sus Vacunas S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
5.02%
Total operating revenue
5.02%
Operating profit (EBIT)
12.8%
Net Profit (Loss) for the Period
-47.65%
Total assets
10.88%
Total equity
2.29%
Operating Profit Margin (ROS)
0.57%
Net Profit Margin
-2.91%
Return on Equity (ROE)
-10.53%
Quick Ratio
0.08%
Cash Ratio
0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?